What is uterine fibroid embolisation?
Uterine fibroid embolisation (UFE/UAE) blocks the arteries feeding fibroids using a thin catheter placed via the groin or wrist. Starved of blood supply, the fibroid shrinks over time and symptoms ease. The uterus is preserved; the procedure is performed by interventional radiology and is an established method with long-term data.
How does it work?
Under angiographic guidance the uterine arteries are reached and small particles are delivered into the branches feeding the fibroid. Without blood supply the fibroid begins to shrink over weeks to months. The procedure usually needs no incision — just a small puncture at the entry point.
Who is it often considered for?
A strong option for patients with symptomatic fibroids who prefer not to have surgery or are unsuitable for it; its ability to target multiple fibroids at once is a notable advantage. For patients planning pregnancy the picture is more nuanced, and embolisation’s place should be discussed in detail with your physician.
For patients planning pregnancy, the embolisation decision is recommended to be individual and weighed alongside the alternatives.
Source: 2021 · Obstetrics & Gynecology — klinik guideline2022 · BMC Women's Health
After the procedure: post-embolisation syndrome
The honest part of this method is the first days of recovery: cramping pain, mild fever and fatigue — post-embolisation syndrome — are common, expected and managed with pain control. Most patients return to daily life within days; full recovery varies by person.
How does it differ from HIFU?
Both methods preserve the uterus and avoid surgical incisions; they differ in mechanism and profile. Embolisation cuts the fibroid’s blood supply; HIFU targets the tissue with heat. Which profile fits you is covered, with evidence, on our comparison page.